Literature DB >> 1246375

Progestational potency of oral contraceptives.

R P Dickey, S C Stone.   

Abstract

The induction of glycogen deposition as subnuclear vacuoles was found to be a better method in estimating progestational potency of individual progestins than the delay of menses assay. Norgestrel was the most potent progestin in all assays. The progestational potency of oral contraceptives was estimated by multiply potency of individual progestins by their dose. Combination oral contraceptives containing norgestrel were in the mid range of progestational potency because of the relatively higher potency of their progestin. The progestational potency of the norethindrone "mini" pill was compared with that of the norethindrone low-progestogen combination pill and the sequential pill over a 28-day cycle, and no appreciable difference was found.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246375

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Which pill?

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

2.  Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.

Authors:  R H Down; M J Whiting; J M Watts; W Jones
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

3.  Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA).

Authors:  L F Voigt; Q Deng; N S Weiss
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

Review 4.  Determination of progestational potency: a review.

Authors:  G I Swyer
Journal:  J R Soc Med       Date:  1984-05       Impact factor: 18.000

5.  An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk.

Authors:  S A Lee; R K Ross; M C Pike
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.